AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Non-Reccuring Items
AstraZeneca PLC
Non-Reccuring Items Peer Comparison
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Non-Reccuring Items
-$723m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Non-Reccuring Items
-£897m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Non-Reccuring Items
-$274m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Non-Reccuring Items
-$260m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-30%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Non-Reccuring Items
-£40m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-63%
|
See Also
What is AstraZeneca PLC's Non-Reccuring Items?
Non-Reccuring Items
-723m
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Non-Reccuring Items amounts to -723m USD.
What is AstraZeneca PLC's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 1Y
86%
Over the last year, the Non-Reccuring Items growth was 86%.